Latest Earnings Results: Q2 '26
Estimated EPS
-$0.08
Reported EPS
-$0.07
Surprise
+14.63%
Estimated Rev
$13.18M
Reported Rev
$13.88M
Surprise
+5.38%
$APYX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.07 up 22.22% YoY • Reported revenue of $13.88M up 22.08% YoY • Apyx Medical Corporation reaffirmed its full year 2026 revenue guidance of $59.0 million to $60.0 million and continues to expect operating expenses of less than $45.0 million for the year.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.10 | -- | -- | N/A |
Q2 '26 | -$0.08 | -$0.07 | 14.63% | BEAT |
Q1 '26 | -$0.11 | -$0.05 | 54.55% | BEAT |
Q4 '25 | -$0.05 | -$0.03 | 38.40% | BEAT |
Q3 '25 | -$0.10 | -$0.05 | 51.16% | BEAT |